These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
899 related articles for article (PubMed ID: 26200270)
1. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer. Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270 [TBL] [Abstract][Full Text] [Related]
2. [Diagnostic Value of Folate Receptor-positive Circulating Tumor Cell in Lung Cancer: A Pilot Study]. Lian H; Ding Z; Yuan D; Ma J; Qin J Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):813-820. PubMed ID: 27978866 [TBL] [Abstract][Full Text] [Related]
3. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer. Jiang ZF; Wang M; Xu JL Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745 [TBL] [Abstract][Full Text] [Related]
4. [Detection and diagnostic value of serum carcinoembryonic antigen and cytokeratin 19 fragment in lung cancer patients]. Hang ZQ; Zheng MF; Huang JH Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):847-9. PubMed ID: 22335951 [TBL] [Abstract][Full Text] [Related]
5. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer. Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790 [TBL] [Abstract][Full Text] [Related]
6. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer. Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607 [TBL] [Abstract][Full Text] [Related]
7. Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancer. Bai Y; Shen W; Zhu M; Zhang L; Wei Y; Tang H; Zhao J J Cell Biochem; 2019 Jan; 120(1):105-114. PubMed ID: 30216488 [TBL] [Abstract][Full Text] [Related]
8. Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancer. Sun N; Chen Z; Tan F; Zhang B; Yao R; Zhou C; Li J; Gao Y; Liu Z; Tan X; Zhou F; He MY; Shao K; Li N; Qiu B; Sun J; Yu Y; Wang S; Zhao Y; Shi X; He J Clin Cancer Res; 2013 Sep; 19(18):5136-45. PubMed ID: 24046070 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Serum MicroRNA21 and Tumor Markers in Diagnosis of Early Non-Small Cell Lung Cancer. Sun M; Song J; Zhou Z; Zhu R; Jin H; Ji Y; Lu Q; Ju H Dis Markers; 2016; 2016():3823121. PubMed ID: 26880855 [TBL] [Abstract][Full Text] [Related]
10. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer. Chen X; Wang X; He H; Liu Z; Hu JF; Li W PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878 [TBL] [Abstract][Full Text] [Related]
11. The Diagnostic and Prognostic Value of the Combination of Tumor M2-Pyruvate Kinase, Carcinoembryonic Antigen, and Cytokeratin 19 Fragment in Non-Small Cell Lung Cancer. Li L; Xu Y; Wang Y; Zhang Q; Wang Y; Xu C Technol Cancer Res Treat; 2024; 23():15330338241265983. PubMed ID: 39043046 [No Abstract] [Full Text] [Related]
12. Diagnostic potential of protein serum biomarkers for distinguishing small and non-small cell lung cancer in patients with suspicious lung lesions. Sua LF; Serrano-Gomez SJ; Nuñez M; Amezquita-Dussan MA; Fernández-Trujillo L Biomarkers; 2024 Jul; 29(5):315-323. PubMed ID: 38804910 [TBL] [Abstract][Full Text] [Related]
13. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis. Cui C; Sun X; Zhang J; Han D; Gu J J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270 [TBL] [Abstract][Full Text] [Related]
14. Serum cyfra21-1 as a biomarker in patients with nonsmall cell lung cancer. Zhao H; Shi X; Liu J; Chen Z; Wang G J Cancer Res Ther; 2014 Nov; 10 Suppl():C215-7. PubMed ID: 25450285 [TBL] [Abstract][Full Text] [Related]
15. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China. Ma L; Xie XW; Wang HY; Ma LY; Wen ZG Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610 [TBL] [Abstract][Full Text] [Related]
16. Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR. Lou J; Ben S; Yang G; Liang X; Wang X; Ni S; Han B PLoS One; 2013; 8(12):e80458. PubMed ID: 24324600 [TBL] [Abstract][Full Text] [Related]
17. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients. Zhang L; Liu D; Li L; Pu D; Zhou P; Jing Y; Yu H; Wang Y; Zhu Y; He Y; Li Y; Zhao S; Qiu Z; Li W BMC Cancer; 2017 Feb; 17(1):96. PubMed ID: 28152979 [TBL] [Abstract][Full Text] [Related]
18. Serum carcinoembryonic antigen, neuron-specific enolase as biomarkers for diagnosis of nonsmall cell lung cancer. Dong Y; Zheng X; Yang Z; Sun M; Zhang G; An X; Pan L; Zhang S J Cancer Res Ther; 2016 Oct; 12(Supplement):34-36. PubMed ID: 27721249 [TBL] [Abstract][Full Text] [Related]
19. The diagnostic and prognostic value of ProGRP in lung cancer. Nisman B; Biran H; Ramu N; Heching N; Barak V; Peretz T Anticancer Res; 2009 Nov; 29(11):4827-32. PubMed ID: 20032442 [TBL] [Abstract][Full Text] [Related]
20. Serum carbohydrate sulfotransferase 7 in lung cancer and non-malignant pulmonary inflammations. Debeljak Ž; Dundović S; Badovinac S; Mandić S; Samaržija M; Dmitrović B; Miloš M; Maričić L; Šerić V; Buljanović V Clin Chem Lab Med; 2018 Jul; 56(8):1328-1335. PubMed ID: 29648993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]